Shire, Barr In Talks To Settle Aderall XR Patent Challenge

Law360, New York (August 19, 2005, 12:00 AM EDT) -- U.K. drug maker Shire Pharmaceuticals is in talks with Barr Laboratories to try to settle out of court a patent challenge to Shire’s blockbuster hyperactivity drug Adderall XR.

The two companies initially refused to comment on rumors that they had struck a deal, but Shire was forced to make a statement on Friday after its stock prise rose markedly.

The two companies are involved in litigation concerning Barr's efforts to market a generic version of Shire's Adderall XR prior to the expiration of the Shire patents,...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.